TABLE 1
FROM:
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Nish Chaturvedi, Simona Bandinelli, Ruggero Mangili, Guiseppe Penno, Raoul E Rottiers and John H Fuller on behalf of the EURODIAB Prospective Complications Study Group
BACK TO ARTICLETable 1. Comparison of baseline data for those with and without an albumin excretion rate (AER) measurement at follow-up
| Availability of AER measurement at follow-up | |||
|---|---|---|---|
| No (N = 691) | Yes (N = 1134) | P value | |
| Age years | 32 10 | 32 10 | 0.1 |
| Duration years | 13 9 | 14 9 | 0.7 |
| HbA1c % | 6.7 1.8 | 6.3 1.7 | 0.0001 |
AERa g/min
| 7.7 (5.2, 11.6) | 7.9 (5.6, 11.8) | 0.3 |
| Systolic BP mm Hg | 118 16.8 | 118 14.9 | 0.3 |
| Diastolic BP mm Hg | 74 10.4 | 73.4 10.7 | 0.5 |
| Cholesterol mmol/L | 5.2 1.1 | 5.2 1.0 | 0.1 |
| Triglyceridea mmol/L | 0.96 (0.75, 1.21) | 0.89 (0.65, 1.12) | 0.004 |
| WHR | 0.84 0.11 | 0.83 0.10 | 0.6 |
Data are mean
SD. Abbreviations are: BP, blood pressure; WHR, waist to hip ratio.
a Geometric mean (25th, 75th centiles)

g/min